Search Results

The DataPro™/DataPro Plus™ Clinical Chemistry Analyzer is a fully automated clinical chemistry analyzer intended for routine diagnostic clinical laboratory use. The DataPro™ has replaceable parts, automated maintenance monitoring and backup of both patient and system data. With a throughput of up to 230 tests per hour, the DataPro™ is intended for small and medium-sized laboratories, or as a backup analyzer in large volume laboratories.

The DataPro™/DataPro Plus™ Clinical Chemistry Analyzer is intended to be used in the diagnosis of disease or other conditions, including a determination of the state of health, in order to cure, mitigate, treat, or prevent disease or its sequelae related to the measurement of various clinical assays, such as Albumin, Alkaline Phosphatase, Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST), Urea Nitrogen (BJ N), Calcium, Cholesterol, Creatinine, Direct Bilirubin, Glucose, Phosphorus, Total Billirubin, Total Protein, Triglyceride, and Uric Acid.

The DataPro™, and all of the reagents included in this test system are for in vitro diagnostic use only.

The DataPro™/DataPro Plus™ Clinical Chemistry Analyzer is a fully automated clinical chemistry analyzer intended for routine diagnostic clinical laboratory use. The DataPro™ has replaceable parts, automated maintenance monitoring and backup of both patient and system data. With a throughput of up to 230 tests per hour, the DataPro™ is intended for small and medium-sized laboratories, or as a backup analyzer in large volume laboratories.

The provided text is a 510(k) premarket notification approval letter for a clinical chemistry analyzer. It does not contain the detailed acceptance criteria or a study proving that the device meets those criteria, as typically found in a clinical study report or a detailed validation document.

This document primarily states that the FDA has reviewed the device and determined it to be substantially equivalent to legally marketed predicate devices. It lists the "Indications for Use" for the DataPro™/DataPro Plus™ Clinical Chemistry Analyzer, which describes its intended purpose and the types of assays it can perform.

Therefore, I cannot provide the requested information based on the given input regarding:

1. A table of acceptance criteria and the reported device performance
2. Sample sizes used for the test set and data provenance
3. Number of experts and qualifications
4. Adjudication method
5. MRMC comparative effectiveness study results
6. Standalone performance
7. Type of ground truth used
8. Sample size for the training set
9. Ground truth establishment for the training set

The document is purely an FDA approval letter, not a technical study report.

Ask a specific question about this device